These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32768016)

  • 41. Which strategy is "best" after myocardial infarction? The Beta-blocker Strategy plus Implantable Cardioverter Defibrillator Trial: rationale and study design.
    Raviele A; Bongiorni MG; Brignole M; Cappato R; Capucci A; Gaita F; Mangiameli S; Montenero A; Pedretti R; Salerno J; Sermasi S
    Am J Cardiol; 1999 Mar; 83(5B):104D-111D. PubMed ID: 10089851
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?
    Armoundas AA; Hohnloser SH; Ikeda T; Cohen RJ
    Nat Clin Pract Cardiovasc Med; 2005 Oct; 2(10):522-8. PubMed ID: 16186850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    Sugawara M; Kondo Y; Ryuzaki S; Yoshino Y; Chiba T; Ito R; Kajiyama T; Nakano M; Kobayashi Y
    J Cardiol; 2024 Sep; 84(3):170-176. PubMed ID: 38382578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ventricular arrhythmias and sudden cardiac death: an insight from recent multicenter randomized clinical trials.
    Akiyama T
    Keio J Med; 1996 Dec; 45(4):313-7. PubMed ID: 9023449
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Whether to implant a defibrillator or not? The Possibility of Using the MADIT-ICD Benefit Score Calculator in Real Practice].
    Ilov NN; Boytsov SA; Nechepurenko AA
    Kardiologiia; 2024 Feb; 64(2):27-33. PubMed ID: 38462801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).
    Zareba W; Piotrowicz K; McNitt S; Moss AJ;
    Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Failure to reassess ejection fraction after acute myocardial infarction in potential implantable cardioverter/defibrillator candidates: insights from the Translational Research Investigating Underlying disparities in acute Myocardial infarction Patients' Health Status (TRIUMPH) registry.
    Miller AL; Gosch K; Daugherty SL; Rathore S; Peterson PN; Peterson ED; Ho PM; Chan PS; Lanfear DE; Spertus JA; Wang TY
    Am Heart J; 2013 Oct; 166(4):737-43. PubMed ID: 24093855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of the right ventricular lead position on clinical outcome and on the incidence of ventricular tachyarrhythmias in patients with CRT-D.
    Kutyifa V; Bloch Thomsen PE; Huang DT; Rosero S; Tompkins C; Jons C; McNitt S; Polonsky B; Shah A; Merkely B; Solomon SD; Moss AJ; Zareba W; Klein HU
    Heart Rhythm; 2013 Dec; 10(12):1770-7. PubMed ID: 23973954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.
    Sherazi S; Shah F; Kutyifa V; McNitt S; Aktas MK; Polonsky B; Zareba W; Goldenberg I
    JACC Clin Electrophysiol; 2019 Oct; 5(10):1172-1181. PubMed ID: 31648742
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of elapsed time from coronary revascularization to implantation of a cardioverter defibrillator on long-term survival in the MADIT-II trial.
    Barsheshet A; Goldenberg I; Moss AJ; Huang DT; Zareba W; McNitt S; Klein HU; Guetta V
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1237-42. PubMed ID: 21615813
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevalence and clinical course of patients in Spain with acute myocardial infarction and severely depressed ejection fraction who meet the criteria for automatic defibrillator implantation].
    Martí Almor J; Delclós Baulies M; Delclós Urgell J; Comín Colet J; Cladellas Capdevila M; Bruguera Cortada J
    Rev Esp Cardiol; 2004 Jul; 57(7):705-8. PubMed ID: 15274858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early echocardiographic deformation analysis for the prediction of sudden cardiac death and life-threatening arrhythmias after myocardial infarction.
    Ersbøll M; Valeur N; Andersen MJ; Mogensen UM; Vinther M; Svendsen JH; Møller JE; Kisslo J; Velazquez EJ; Hassager C; Søgaard P; Køber L
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):851-60. PubMed ID: 23850252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MADIT-II: clinical implications.
    Moss AJ; Daubert J; Zareba W
    Card Electrophysiol Rev; 2002 Dec; 6(4):463-5. PubMed ID: 12438829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK; Guo H; Moss AJ; Olshansky B; McNitt SA; Hall WJ; Zareba W; Steinberg JS; Fischer A; Ruskin J; Andrews ML;
    J Am Coll Cardiol; 2006 Feb; 47(4):769-73. PubMed ID: 16487843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk stratification using heart rate turbulence and ventricular arrhythmia in MADIT II: usefulness and limitations of a 10-minute holter recording.
    Berkowitsch A; Zareba W; Neumann T; Erdogan A; Nitt SM; Moss AJ; Pitschner HF
    Ann Noninvasive Electrocardiol; 2004 Jul; 9(3):270-9. PubMed ID: 15245344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognosis of Type 2 Myocardial Infarction Patients Implanted With a Prophylactic Defibrillator (from the Very-High-Rate Registry).
    David C; Bisson A; André C; Pierre B; Bernard A; Fauchier L; Angoulvant D; Babuty D; Clementy N
    Am J Cardiol; 2020 Apr; 125(7):1001-1005. PubMed ID: 31932082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Variability of Holter electrocardiographic findings in patients fulfilling the noninvasive MADIT criteria. Multicenter Automatic Defibrillator Implantation Trial.
    Senges JC; Becker R; Schreiner KD; Bauer A; Weretka S; Siegler K; Kuebler W; Schoels W
    Pacing Clin Electrophysiol; 2002 Feb; 25(2):183-90. PubMed ID: 11915985
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.